Defining the heterogeneous molecular landscape of lung cancer cell responses to epigenetic inhibition

Key Points

• Lung cancer cell responses vary significantly to epigenetic inhibition, indicating diverse treatment possibilities.
• A detailed characterization reveals distinct molecular pathways impacting cell reactions to therapies.
• Analysis of biological samples showcases the heterogeneous landscape influenced by genetic and epigenetic factors.
• These findings may enable customized therapies, highlighting the need for tailored cancer treatment strategies.